Skip to content

Clase Neera

Reporting owner on Forms 3, 4 and 5, CIK 2162845.

Clase Neera reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-05.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Tarsus Pharmaceuticals, Inc. CIK 1819790officer (Chief Commercial Officer)22026-11-05

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative2026-11-03A granted+10,587$010,587Form 4
TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative2026-11-03A granted+6,678$06,678Form 4
TARS · Tarsus Pharmaceuticals, Inc.Common Stock, holding 14,800Form 3
TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding Form 3
TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding Form 3
TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding Form 3
TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding Form 3
TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding Form 3
TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding Form 3
TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative, holding Form 3
TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative, holding Form 3
TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative, holding Form 3
TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative, holding Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0002162845-26-000005 Tarsus Pharmaceuticals, Inc.2026-11-05
Form 3 0002162845-26-000004 Tarsus Pharmaceuticals, Inc.2026-11-05